Stereotaxis Inc (STXS)

Currency in USD
1.010
+0.064(+6.76%)
Closed·
1.030+0.020(+1.99%)
·
STXS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.9501.070
52 wk Range
0.8002.860
Key Statistics
Prev. Close
1.01
Open
0.951
Day's Range
0.95-1.07
52 wk Range
0.8-2.86
Volume
1.39M
Average Volume (3m)
699.44K
1-Year Change
-54.9107%
Book Value / Share
0.21
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
STXS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.667
Upside
+164.03%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

Stereotaxis Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 2.667
(+164.03% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
TD Cowen
Buy2.00+98.02%3.00MaintainNov 11, 2026
Citizens
Buy3.00+197.03%4.00MaintainAug 27, 2026
Citizens
Buy4.00+296.04%-MaintainJun 03, 2026
Piper Sandler
Buy3.50+246.53%4.00MaintainMay 13, 2026
Citizens
Buy4.00+296.04%-MaintainApr 01, 2026

Stereotaxis Inc Earnings Call Summary for Q3/2026

  • Stereotaxis posted Q3 revenue of $8.9M, up 20% YoY but missing estimates by 10%; adjusted loss of $0.07/share exceeded forecast loss of $0.05
  • Stock plunged 22.6% to $0.882 in after-hours trading following the miss; shares now down 63% over past twelve months to $105M market cap
  • MAGiC catheter supply constraints and J&J transition pressured recurring revenue; company secured $12M convertible note financing, lifting liquidity to $28M
  • Management projects profitability in 2027 with operating expenses normalizing at $8M/quarter; first U.S. GenesisX installation expected imminently
  • Pipeline includes 24 GenesisX opportunities and 50 Synchrony systems over next year; Q4 recurring revenue expected to reach high watermark despite constraints
Last Updated: 11/11/2026, 06:32 AM
Read Full Transcript

Earnings

Latest Release
Nov 10, 2026
EPS / Forecast
-0.07 / -0.05
Revenue / Forecast
8.92M / 9.93M
EPS Revisions
Last 90 days

STXS Income Statement

Compare STXS to Peers and Sector

Metrics to compare
STXS
Peers
Sector
Relationship
P/E Ratio
−4.3x−1.1x−0.2x
PEG Ratio
−0.30−0.160.00
Price/Book
4.8x2.1x2.6x
Price / LTM Sales
3.2x2.3x2.7x
Upside (Analyst Target)
164.0%98.1%72.2%
Fair Value Upside
Unlock16.5%12.4%Unlock

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.23M10.14%9.67M
Other Institutional Investors
35.40M35.11%33.49M
Public Companies & Retail Investors
55.20M54.75%52.23M
Total
100.83M100.00%95.39M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dafna Capital Management, LLC13.57%13,680,55412,943
BlackRock, Inc.4.36%4,396,8354,160

People Also Watch

2.7100
PDYN
-5.24%
44.91
CRWV
-6.10%
18.81
LKQ
-1.52%
141.48
KLAC
-2.35%
587.43
PWR
-2.52%

FAQ

What Is the Stereotaxis (STXS) Stock Price Today?

The Stereotaxis stock price today is 1.010 USD.

What Stock Exchange Does Stereotaxis Trade On?

Stereotaxis is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Stereotaxis?

The stock symbol for Stereotaxis is "STXS."

What Is the Stereotaxis Market Cap?

As of today, Stereotaxis market cap is 101.860M USD.

What Is Stereotaxis's Earnings Per Share (TTM)?

The Stereotaxis EPS (TTM) is -0.24.

When Is the Next Stereotaxis Earnings Date?

Stereotaxis will release its next earnings report on Feb 26, 2027.

From a Technical Analysis Perspective, Is STXS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Stereotaxis Stock Split?

Stereotaxis has split 2 times.

How Many Employees Does Stereotaxis Have?

Stereotaxis has 131 employees.

What is the current trading status of Stereotaxis (STXS)?

As of Nov 20, 2026, Stereotaxis (STXS) is trading at a price of 1.010 USD, with a previous close of 1.010 USD. The stock has fluctuated within a day range of 0.950 USD to 1.070 USD, while its 52-week range spans from 0.800 USD to 2.860 USD.

What Is Stereotaxis (STXS) Price Target According to Analysts?

The average 12-month price target for Stereotaxis is 2.667 USD, with a high estimate of 3 USD and a low estimate of 2 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +164.03% Upside potential.

What Is the STXS Premarket Price?

STXS's last pre-market stock price is 1.030 USD. The pre-market share volume is 16,900.000, and the stock has decreased by 0.020, or 1.990%.

What Is the STXS After Hours Price?

STXS's last after hours stock price is 1.120 USD, the stock has decreased by 0.110, or 10.890%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.